Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v1-EN
Language English English
Date Updated 2021-09-18 2021-08-16
Drug Identification Number 02276429 02276429
Brand name FOSAVANCE FOSAVANCE
Common or Proper name alendronate sodium / cholecalciferol tablets alendronate sodium / cholecalciferol tablets
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients VITAMIN D3 ALENDRONIC ACID VITAMIN D3 ALENDRONIC ACID
Strength(s) 2800UNIT 70MG 2800UNIT 70MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4 4
ATC code M05BB M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-09-03 2021-08-27
Actual start date 2021-09-03
Estimated end date 2021-09-20 2021-10-08
Actual end date 2021-09-17
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments